Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • mengal
    Junior Member
    • Jan 2018
    • 4

    Biological replicates

    Hello everyone,

    I am working on infertility of male cattleyak, RNA-seq data. I have cattle fertile and cattleyak infertile epididymal tissue samples.I have sent the tissue sample to a company for RNA seq (C1, C2, C3- Y1, Y2, Y3) but the company couldn't,t get the good quality RNA for C1 biological replicate and the excluded that so now the results for comparison I have is like this (C2, C3- Y1, Y2, Y3) is that okay to processed with results


    -Can anybody tell me what to do??

    Please help & tell me how should I proceed.
  • sdriscoll
    I like code
    • Sep 2009
    • 436

    #2
    What you're probably concerned with is if you can rely on differential expression results from a small sample size such as 2 vs 3. The differential expression tools (DESeq2, edgeR, etc..) have very low false positive rates even with small sample sizes. Unfortunately they also likely have pretty high false negative rates at low sample sizes. So you're far more likely to be missing significant hits than getting false hits. This is true of even 5 vs 5 or 10 vs 10. They statistical analysis has been designed to have a low false positive rate in all cases.

    In short, I'd say if you were planning to have a 3 vs 3 and now you have a 2 vs 3 you're not losing much. But you really don't know for certain until you see the data. Sometimes we sequence something we haven't sequenced before and it turns out that it's far more variable from sample to sample than other things and so our usual 3 biological replicates isn't sufficient anymore. I'd say you're gonna be OK and any positive hits you get back from a differential test should be reliable.
    /* Shawn Driscoll, Gene Expression Laboratory, Pfaff
    Salk Institute for Biological Studies, La Jolla, CA, USA */

    Comment

    • mengal
      Junior Member
      • Jan 2018
      • 4

      #3
      bundle of thanks for your kind reply

      Comment

      • mengal
        Junior Member
        • Jan 2018
        • 4

        #4
        kindly tell me what to do next the company has done the analysis in two ways (M1, M2, M3, VS P2, P3) And (M1, M2, VS P2, P3) and there is a very big difference in DEGs. for the first combination the number of DEGs is (3008) and for the second one it's(6712) this is the url link for the Pearson's correlation coefficient r (Pearson's Correlation Coefficient) as biological repeat correlation assessment" and <a href="http://pt-br.tinypic.com?ref=10r95rb" target="_blank"><img src="http://i67.tinypic.com/10r95rb.jpg" border="0" alt="Image and video hosting by TinyPic"></a>" if you can kindly help cuz i'm a new researcher in this field it is very difficult for me take a decision.

        thanks

        Comment

        • torben
          Member
          • Oct 2012
          • 21

          #5
          Originally posted by mengal View Post
          [T]he company has done the analysis in two ways (M1, M2, M3, VS P2, P3) And (M1, M2, VS P2, P3) and there is a very big difference in DEGs. for the first combination the number of DEGs is (3008) and for the second one it's(6712)
          From the numbers I would assume that the second combination (M1, M2, VS P2, P3) was done as a paired test. However, from the description of your experimental setup there's no pairing so you should discard this analysis.

          Comment

          • mengal
            Junior Member
            • Jan 2018
            • 4

            #6
            Originally posted by torben View Post
            From the numbers I would assume that the second combination (M1, M2, VS P2, P3) was done as a paired test. However, from the description of your experimental setup, there's no pairing so you should discard this analysis.
            Do you mean I should discard the second combination (M1, M2, VS P2, P3) and go with this combination (M1, M2, M3 VS P2, P3) ??

            I really appreciate if you could kindly share your email ID. I really need your help because I Don't have a supervisor for this project and I'm confused with the results. this is my email id: [email protected]

            thanks

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Nine Things a Sample Prep Scientist Thinks About Before Sequencing
              by SEQadmin2


              I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.


              Here are nine questions we think about, in roughly the order they matter, before...
              Yesterday, 07:11 AM
            • SEQadmin2
              From Collection to Sequencing: Why Sample Preparation and Preservation Define Sequencing Data
              by SEQadmin2


              Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.


              The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
              ...
              06-02-2026, 10:05 AM
            • SEQadmin2
              Single-Cell Sequencing at an Inflection Point: Early Impacts of New Platforms and Emerging Trends
              by SEQadmin2


              With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.


              Introduction

              Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...
              05-22-2026, 06:42 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 06-17-2026, 06:09 AM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 06-09-2026, 11:58 AM
            0 responses
            38 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 06-05-2026, 10:09 AM
            0 responses
            44 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 06-04-2026, 08:59 AM
            0 responses
            49 views
            0 reactions
            Last Post SEQadmin2  
            Working...